Evidence for the Nitric Oxide Pathway as a Potential Mode of Action in Fenoldopam-induced Vascular Injury

Toxicologic Pathology

Volumn 40, Issue 6, 2012, Pages 874-886

  Brott, David A ^a   Richardson, Rudy J ^b   Louden, Calvert S ^c  

^a ASTRAZENECA   (United Kingdom)

^b UNIVERSITY OF MICHIGAN   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

caveolin 1; DIVI; drug induced vascular injury; extracellular superoxide dismutase (ecSOD); nitric oxide; rat; vasodilatation

Indexed keywords

CAVEOLIN 1; CLAUDIN; CONNEXIN 43; FENOLDOPAM; NITRIC OXIDE; PROTEIN ZO1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INJURY SEVERITY; MALE; MESENTERIC ARTERY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; VASODILATATION;

ANALYSIS OF VARIANCE; ANIMALS; CASPASE 3; CAVEOLIN 1; CELL SURVIVAL; FENOLDOPAM; IMMUNOHISTOCHEMISTRY; MALE; MESENTERIC ARTERIES; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PEROXYNITROUS ACID; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; VASCULAR SYSTEM INJURIES;

RATTUS;

EID: 84865984522     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623312444027     Document Type: Article

References (54)

1. Albassam M. A. Metz A. L. Gragtmans N. J. King L. M. Macallum G. E. Hallak H. McGuire E. J. (1999). Coronary arteriopathy in monkeys following administration of CI-1020, an endothelin A receptor antagonist. Toxicol Pathol 27, 156–64.
2. Brott D. A. Jones H. B. Gould S. Valentin J. P. Evans G. Richardson R. J. Louden C. (2005). Current status and future directions for diagnostic markers of drug-induced vascular injury. Cancer Biomark 1, 15–28.
3. Brott D. Gould S. Jones H. Schofield J. Prior H. Valentin J. P. Bjurstrom S. Kenne K. Schuppe-Koistinen I. Katein A. Foster-Brown L. Betton G. Richardson R. Evans G. Louden C. (2005). Biomarkers of drug-induced vascular injury. Toxicol Appl Pharmacol 207, S441–45.
4. Bugelski P. J. Vockley C. M. Sowinski J. M. Arena E. Berkowitz B. A. Morgan D. G. (1989). Ultrastructure of an arterial lesion induced in rats by fenoldopam mesylate, a dopaminergic vasodilator. Br J Exp Pathol 70, 153–65.
5. Chelly J. E. Doursout M. F. Begaud B. Tsao C. C. Hartley C. J. (1986). Effects of hydralazine on regional blood flow in conscious dogs. J Pharmacol Exp Ther 238, 665–69.
6. Collins J. J. Elwell M. R. Lamb J. C. Manus A. G. Heath J. E. Makovec G. T. (1988). Subchronic toxicity of orally-administered (gavage and dosed-feed) theophylline in Fischer 344 rats and B6C3F1 mice. Fundam Appl Toxicol 11, 472–84.
7. Dietsch G. N. DiPalma C. R. Eyre R. J. Pham T. Q. Poole K. M. Pefaur N. B. Welch W. D. Trueblood E. Kerns W. D. Kanaly S. T. (2006). Characterization of the inflammatory response to a highly selective PDE4 inhibitor in the rat and the identification of biomarkers that correlate with toxicity. Toxicol Pathol 34, 39–51.
8. Dogterom P. Zbinden G. Reznik G. K. (1992). Cardiotoxicity of vasodilators and positive inotropic/vasodilating drugs in dogs: an overview. Crit Rev Toxicol 22, 203–41.
9. Drab M. Verkade P. Elger M. Kasper M. Lohn M. Lauterbach B. Menne J. Lindschau C. Mende F. Luft F. C. Schedl A. Haller H. Kurzchalia T. V. (2001). Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293, 2449–52.
10. Feron O. Kelly R. A. (2001). The caveolar paradox: suppressing, inducing and termination eNOS signaling. Circ Res 88, 129–31.
11. Frank P. G. Lisanti M. P. (2006). Role of caveolin-1 in the regulation of the vascular shear stress response. J Clin Invest 116, 1222–5.
12. Fukai T. Folz R. J. Landmesser U. Harrison D. G. (2002). Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res 55, 239–49.
13. Gans J. H. Korson R. Cater M. R. Ackerly C. C. (1980). Effects of short-term and long-term theobromine administration to male dogs. Toxicol Appl Pharmacol 53, 481–96.
14. Garcia-Cardena G. Martasek P. Masters B. S. Skidd P. M. Couet J. Li S. Lisanti M. P. Sessa W. C. (1997). Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. J Biol Chem 272, 25437–40.
15. Greaves P. (1998). Patterns of drug-induced cardiovascular pathology in the beagle dog: relevance for humans. Exp Toxicol Pathol 50, 283–93.
16. Humphrey S. J. Zins G. R. (1984). Whole body and regional hemodynamic effects of minoxidil in conscious dogs. J Cardiovasc Pharmacol 6, 979–88.
17. Johansson S. (1981). Cardiovascular lesions in Sprague-Dawley rats induced by long-term treatment with caffeine. Acta Pathol Microbiol Immunol Scand [A] 89, 185–91.
18. Joseph E. C. (2000). Arterial lesions induced by phosphodiesterase III (PDE III) inhibitors and DA(1) agonists. Toxicol Lett 112–113, 537–46.
19. Joseph E. C. Mesfin G. M. Kerns W. D. (1997). Pathogenesis of arterial lesions caused by vasoactive compounds in laboratory animals. In Cardiovascular Toxicology (Bishop D. P. Kerns W. E., eds.), pp. 279–307. Pergamon, New York, NY.
20. Karlsson K. Marklund S. L. (1987). Heparin-induced release of extracellular superoxide dismutase to human blood plasma. Bichochem J 242: 55–9.
21. Kerns W. D. Arena E. Macia R. A. Bugelski P. J. Matthews W. D. Morgan D. G. (1989). Pathogenesis of arterial lesions induced by dopaminergic compounds in the rat. Toxicol Pathol 17, 203–13.
22. Kerns W. D. Arena E. Morgan D. G. (1989). Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat. Am J Pathol 135, 339–49.
23. Kerns W. Schwartz L. Blanchard K. Burchiel S. Essayan D. Fung E. Johnson R. Lawton M. Louden C. MacGregor J. Miller F. Nagarkatti P. Robertson D. Snyder P. Thomas H. Wagner B. Ward A. Zhang J. (2005). Expert working group on drug-induced vascular injury: Drug-induced vascular injury–a quest for biomarkers. Toxicol Appl Pharmacol 203, 62–87.
24. Kuhlmann C. R. Trumper J. R. Abdallah Y. Wiebke Ludders D. Schaefer C. A. Most A. K. Backenkohler U. Neumann T. Walther S. Piper H. M. Tillmanns H. Erdogan A. (2004). The k+-channel opener NS1619 increases endothelial NO-synthesis involving p42/p44 MAP-kinase. Thromb Haemost 92, 1099–107.
25. Landmesser U. Spiekermann S. Dikalov S. Tatge H. Wilke R. Kohler C. Harrison D. G. Hornig B. Drexler H. (2002). Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: Role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 106: 3073–78.
26. Larson J. L. Pino M. V. Geiger L. E. Simeone C. R. (1996). The toxicity of repeated exposures to rolipram, a type IV phosphodiesterase inhibitor, in rats. Pharmacol Toxicol 78, 44–9.
27. Lau H. K. (2003). Cytotoxicity of nitric oxide donors in smooth muscle cells is dependent on phenotype, and mainly due to apoptosis. Atherosclerosis 166, 223–32.
28. Li J. Li W. Su J. Liu W. Altura B. T. Altura B. M. (2004). Peroxynitrite induces apoptosis in rat aortic smooth muscle cells: possible relation to vascular diseases. Exp Biol Med (Maywood) 229, 264–9.
29. Linder A. E. McCluskey L. P. Cole K. R. Lanning K. M. Webb R. C. (2005). Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta. J Pharmcol Exp Ther 314, 9–15.
30. Liu P. Rudick M. Anderson R. G. (2002). Multiple functions of caveolin-1. J Biol Chem 277, 41295–98.
31. Louden C. Morgan D. G. (2001). Pathology and pathophysiology of drug-induced arterial injury in laboratory animals and its implications on the evaluation of novel chemical entities for human clinical trials. Pharmacol Toxicol 89, 158–70.
32. Louden C. S. Nambi P. Pullen M. A. Thomas R. A. Tierney L. A. Solleveld H. A. Schwartz L. W. (2000). Endothelin receptor subtype distribution predisposes coronary arteries to damage. Am J Pathol 157, 123–34.
33. Marklund S. L. (1984). Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J 222, 649–55.
34. Martens J. R. Sakamoto N. Sullivan S. A. Grobaski T. D. Tamkun M. M. (2001). Isoform-specific localization of voltage-gated K+ channels to distinct lipid raft populations. Targeting of Kv1.5 to caveolae. J Biol Chem 276, 8409–14.
35. Mesfin G. M. Piper R. C. DuCharme D. W. Carlson R. G. Humphrey S. J. Zins G. R. (1989). Pathogenesis of cardiovascular alterations in dogs treated with minoxidil. Toxicol Pathol 17, 164–81.
36. Newsholme S. J. Thudium D. T. Gossett K. A. Watson E. S. Schwartz L. W. (2000). Evaluation of plasma von willebrand factor as a biomarker for acute arterial damage in rats. Toxicol Pathol 28, 688–93.
37. Nusrat A. Parkos C. A. Verkade P. Foley C. S. Liang T. W. Innis-Whitehouse W. Eastburn K. K. Madara J. L. (2000). Tight junctions are membrane microdomains. J Cell Sci 113, 1771–81.
38. Nyska A. Herbert R. A. Chan P. C. Haseman J. K. Hailey J. R. (1998). Theophylline-induced mesenteric periarteritis in F344/N rats. Arch Toxicol 72, 731–7.
39. Ohata H. Adachi T. Hirano K. (1994). Internalization of human extracellular superoxide dismutase by bovine aortic endothelial cells. Free Rad Biol Med 16, 501–7.
40. Oury T. D. Day B. J. Crapo J. D. (1996). Extracellular superoxide dismutase: a regulator of nitric oxide bioavability. Lab Invest 75, 617–36.
41. Radabaugh M. R. Nemirovskiy O. V. Misko T. P. Aggarwal P. Mathews W. R. (2008). Immunoaffinity liquid chromatography-tandem mass spectrometry detection of nitrotyrosine in biological fluids: Development of a clinically translatable biomarker. Analytical Biochem 308, 68–76.
42. Shaul P. W. Anderson R. G. W. (1998). Role of plasmalemmal caveolae in signal transduction. Am J Physiol (Lung Cell Mol Physiol.) 275, L843–51.
43. Slim R. M. Robertson D. G. Albassam M. Reily M. D. Robosky L. Dethloff L. A. (2002). Effect of dexamethasone on the metabonomics profile associated with phosphodiesterase inhibitor-induced vascular lesions in rats. Toxicol Appl Pharmacol 183, 108–16.
44. Slim R. M. Song Y. Albassam M. Dethloff L. A. (2003). Apoptosis and nitrative stress associated with phosphodiesterase inhibitor-induced mesenteric vasculitis in rats. Toxciol Pathol 31, 638–45.
45. Strälin P. Karlsson K. Johansson B. O. Markland S. L. (1995). The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thom Vasc Biol 15, 2032–6.
46. Tirapelli C. R. Casolari D. A. Yogi A. Montezano A. C. Tostes R. C. Legros E. D’Orleans-Juste P. de Oliveira A. M. (2005). Functional characterization and expression of endothelin receptors in rat carotid artery: involvement of nitric oxide, a vasodilator prostanoid and the opening of K+ channels in ETB-induced relaxation. Br J Pharmacol 146, 903–12.
47. Venkatakrishnan U. Chen C. Lokhandwala M. F. (2000). The role of intrarenal nitric oxide in the natriuretic response to dopamine-receptor activation. Clin Exp Hypertens 22, 309–24.
48. Ventura H. O. Messerli F. H. Frohlich E. D. Kobrin I. Oigman W. Dunn F. G. Carey R. M. (1984). Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension. Circulation 69, 1142–45.
49. Yamaguchi T. Murata Y. Fujiyoshi Y. Doi T. (2003). Regulated interaction of endothelin B receptor with caveolin-1. Eur J Biochem 270, 1816–27.
50. Yamamoto M. Okumura S. Oka N. Schwencke C. Ishikawa Y. (1999). Downregulation of caveolin expression by cAMP signal. Life Sci 64, 1349–57.
51. Yu J. Bergaya S. Murata T. Alp I. F. Bauer M. P. Lin M. I. Drab M. Kurzchalia T. V. Stan R. V. Sessa W. C. (2006). Direct evidence for the role of caveolin-1 and caveolae in mechanotransduction and remodeling of blood vessels. J Clin Invest 116, 1284–91.
52. Yu P. Yang Z. Jones J. E. Wang Z. Owens S. A. Mueller S. C. Felder R. A. Jose P. A. (2004). D1 dopamine receptor signaling involved caveolin-2 in HEK-293 cells. Kidney Int 66, 2167–80.
53. Yuhas E. M. Morgan D. G. Arena E. Kupp R. P. Saunders L. Z. Lewis H. B. (1985). Arterial medial necrosis and hemorrhage induced in rats by intravenous infusion of fenoldopam mesylate, a dopaminergic vasodilator. Am J Pathol 119, 83–91.
54. Zhao Y. Y. Liu Y. Stan R. V. Fan L. Gu Y. Dalton N. Chu P. H. Peterson K. Ross J. Jr Chien K. R. (2002). Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc Natl Acad Sci USA 99, 11375–80.